<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2020-08-12" version="221">
<accession>P31994</accession>
<accession>A6H8N3</accession>
<accession>O95649</accession>
<accession>Q53X85</accession>
<accession>Q5VXA9</accession>
<accession>Q8NIA1</accession>
<name>FCG2B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Low affinity immunoglobulin gamma Fc region receptor II-b</fullName>
<shortName>IgG Fc receptor II-b</shortName>
</recommendedName>
<alternativeName>
<fullName>CDw32</fullName>
</alternativeName>
<alternativeName>
<fullName>Fc-gamma RII-b</fullName>
<shortName>Fc-gamma-RIIb</shortName>
<shortName>FcRII-b</shortName>
</alternativeName>
<cdAntigenName>CD32</cdAntigenName>
</protein>
<gene>
<name type="primary">FCGR2B</name>
<name type="synonym">CD32</name>
<name type="synonym">FCG2</name>
<name type="synonym">IGFR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1997-01" db="EMBL/GenBank/DDBJ databases">
<title>Fc-gamma-RIIb nucleotide sequences in SLE and non-SLE humans in vivo derived lymphocytes.</title>
<authorList>
<person name="Ng S."/>
<person name="Sinclair N.R.S."/>
<person name="Anderson C."/>
<person name="Bell D.A."/>
<person name="Cairns E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS IIB1; IIB2; 4 AND 5)</scope>
<scope>VARIANT THR-232</scope>
<source>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="3657" last="3666">
<title>Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.</title>
<authorList>
<person name="Stuart S.G."/>
<person name="Simister N.E."/>
<person name="Clarkson S.B."/>
<person name="Kacinski B.M."/>
<person name="Shapiro M."/>
<person name="Mellman I."/>
</authorList>
<dbReference type="PubMed" id="2531080"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1989.tb08540.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIB2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="J. Exp. Med." volume="170" first="1369" last="1385">
<title>Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.</title>
<authorList>
<person name="Brooks D.G."/>
<person name="Qiu W.Q."/>
<person name="Luster A.D."/>
<person name="Ravetch J.V."/>
</authorList>
<dbReference type="PubMed" id="2529342"/>
<dbReference type="DOI" id="10.1084/jem.170.4.1369"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS IIB1; IIB2 AND IIB3)</scope>
<scope>VARIANT PHE-205</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Eur. J. Immunol." volume="20" first="1367" last="1377">
<title>Distribution, inducibility and biological function of the cloned and expressed human beta Fc receptor II.</title>
<authorList>
<person name="Engelhardt W."/>
<person name="Geerds C."/>
<person name="Frey J."/>
</authorList>
<dbReference type="PubMed" id="2142460"/>
<dbReference type="DOI" id="10.1002/eji.1830200624"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIB2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IIB2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS IIB1 AND IIB2)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Arthritis Rheum." volume="46" first="1242" last="1254">
<title>Fc gamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.</title>
<authorList>
<person name="Kyogoku C."/>
<person name="Dijstelbloem H.M."/>
<person name="Tsuchiya N."/>
<person name="Hatta Y."/>
<person name="Kato H."/>
<person name="Yamaguchi A."/>
<person name="Fukazawa T."/>
<person name="Jansen M.D."/>
<person name="Hashimoto H."/>
<person name="van de Winkel J.G.J."/>
<person name="Kallenberg C.G.M."/>
<person name="Tokunaga K."/>
</authorList>
<dbReference type="PubMed" id="12115230"/>
<dbReference type="DOI" id="10.1002/art.10257"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 132-253</scope>
<scope>INVOLVEMENT IN SLE</scope>
<scope>VARIANT THR-232</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="6305" last="6309">
<title>Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils.</title>
<authorList>
<person name="Hamada F."/>
<person name="Aoki M."/>
<person name="Akiyama T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="8327512"/>
<dbReference type="DOI" id="10.1073/pnas.90.13.6305"/>
</citation>
<scope>INTERACTION WITH FGR</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="4735" last="4743">
<title>In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.</title>
<authorList>
<person name="Bewarder N."/>
<person name="Weinrich V."/>
<person name="Budde P."/>
<person name="Hartmann D."/>
<person name="Flaswinkel H."/>
<person name="Reth M."/>
<person name="Frey J."/>
</authorList>
<dbReference type="PubMed" id="8756631"/>
<dbReference type="DOI" id="10.1128/mcb.16.9.4735"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-292</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Immunol. Lett." volume="57" first="159" last="164">
<title>Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.</title>
<authorList>
<person name="Sarmay G."/>
<person name="Koncz G."/>
<person name="Pecht I."/>
<person name="Gergely J."/>
</authorList>
<dbReference type="PubMed" id="9232445"/>
<dbReference type="DOI" id="10.1016/s0165-2478(97)00055-2"/>
</citation>
<scope>INTERACTION WITH LYN</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Gen. Virol." volume="86" first="1771" last="1784">
<title>Measles virus nucleoprotein induces cell-proliferation arrest and apoptosis through NTAIL-NR and NCORE-FcgammaRIIB1 interactions, respectively.</title>
<authorList>
<person name="Laine D."/>
<person name="Bourhis J.-M."/>
<person name="Longhi S."/>
<person name="Flacher M."/>
<person name="Cassard L."/>
<person name="Canard B."/>
<person name="Sautes-Fridman C."/>
<person name="Rabourdin-Combe C."/>
<person name="Valentin H."/>
</authorList>
<dbReference type="PubMed" id="15914856"/>
<dbReference type="DOI" id="10.1099/vir.0.80791-0"/>
</citation>
<scope>INTERACTION WITH MEASLES VIRUS N PROTEIN (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="1095" last="1103">
<title>Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution.</title>
<authorList>
<person name="Sondermann P."/>
<person name="Huber R."/>
<person name="Jacob U."/>
</authorList>
<dbReference type="PubMed" id="10064577"/>
<dbReference type="DOI" id="10.1093/emboj/18.5.1095"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 46-217</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1993" name="Int. Immunol." volume="5" first="239" last="247">
<title>Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses.</title>
<authorList>
<person name="Warmerdam P.A."/>
<person name="van den Herik-Oudijk I.E."/>
<person name="Parren P.W."/>
<person name="Westerdaal N.A."/>
<person name="van de Winkel J.G."/>
<person name="Capel P.J."/>
</authorList>
<dbReference type="PubMed" id="8466861"/>
<dbReference type="DOI" id="10.1093/intimm/5.3.239"/>
</citation>
<scope>VARIANT ASP-258</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7169" last="7174">
<title>Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.</title>
<authorList>
<person name="Clatworthy M.R."/>
<person name="Willcocks L."/>
<person name="Urban B."/>
<person name="Langhorne J."/>
<person name="Williams T.N."/>
<person name="Peshu N."/>
<person name="Watkins N.A."/>
<person name="Floto R.A."/>
<person name="Smith K.G."/>
</authorList>
<dbReference type="PubMed" id="17435165"/>
<dbReference type="DOI" id="10.1073/pnas.0608889104"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN RESISTANCE TO MALARIA</scope>
<scope>VARIANT THR-232</scope>
<scope>CHARACTERIZATION OF VARIANT THR-232</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="7881" last="7885">
<title>A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.</title>
<authorList>
<person name="Willcocks L.C."/>
<person name="Carr E.J."/>
<person name="Niederer H.A."/>
<person name="Rayner T.F."/>
<person name="Williams T.N."/>
<person name="Yang W."/>
<person name="Scott J.A."/>
<person name="Urban B.C."/>
<person name="Peshu N."/>
<person name="Vyse T.J."/>
<person name="Lau Y.L."/>
<person name="Lyons P.A."/>
<person name="Smith K.G."/>
</authorList>
<dbReference type="PubMed" id="20385827"/>
<dbReference type="DOI" id="10.1073/pnas.0915133107"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>INVOLVEMENT IN SLE</scope>
<scope>VARIANT THR-232</scope>
<scope>INVOLVEMENT IN RESISTANCE TO MALARIA</scope>
</reference>
<comment type="function">
<text>Receptor for the Fc region of complexed or aggregated immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells. Binding to this receptor results in down-modulation of previous state of cell activation triggered via antigen receptors on B-cells (BCR), T-cells (TCR) or via another Fc receptor. Isoform IIB1 fails to mediate endocytosis or phagocytosis. Isoform IIB2 does not trigger phagocytosis.</text>
</comment>
<comment type="subunit">
<text evidence="11 14">Interacts with INPP5D/SHIP1. Interacts with FGR. Interacts with LYN.</text>
</comment>
<comment type="subunit">
<text evidence="7">(Microbial infection) Isoform IIB1 interacts with measles virus protein N. Protein N is released in the blood following lysis of measles infected cells. This interaction presumably block inflammatory immune response.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724784">
<id>P31994</id>
</interactant>
<interactant intactId="EBI-356114">
<id>P01857</id>
<label>IGHG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>31</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724784">
<id>P31994</id>
</interactant>
<interactant intactId="EBI-1380477">
<id>Q92835</id>
<label>INPP5D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724784">
<id>P31994</id>
</interactant>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724784">
<id>P31994</id>
</interactant>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724784">
<id>P31994</id>
</interactant>
<interactant intactId="EBI-78260">
<id>P29350</id>
<label>PTPN6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P31994-1</id>
<name evidence="18">IIB1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P31994-2</id>
<name evidence="18">IIB2</name>
<sequence type="described" ref="VSP_002643"/>
</isoform>
<isoform>
<id>P31994-3</id>
<name evidence="18">IIB3</name>
<sequence type="described" ref="VSP_002642"/>
</isoform>
<isoform>
<id>P31994-4</id>
<name>4</name>
<sequence type="described" ref="VSP_058635"/>
</isoform>
<isoform>
<id>P31994-5</id>
<name>5</name>
<sequence type="described" ref="VSP_058635 VSP_002643"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Is the most broadly distributed Fc-gamma-receptor. Expressed in monocyte, neutrophils, macrophages, basophils, eosinophils, Langerhans cells, B-cells, platelets cells and placenta (endothelial cells). Not detected in natural killer cells.</text>
</comment>
<comment type="domain">
<text>Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases.</text>
</comment>
<comment type="PTM">
<text evidence="13">Phosphorylated by the SRC-type Tyr-kinases LYN and BLK.</text>
</comment>
<comment type="polymorphism">
<text evidence="8 9">FCGR2B polymorphisms can influence susceptibility or resistance to malaria [MIM:611162].</text>
</comment>
<comment type="disease" evidence="6 9">
<disease id="DI-02648">
<name>Systemic lupus erythematosus</name>
<acronym>SLE</acronym>
<description>A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.</description>
<dbReference type="MIM" id="152700"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="caution">
<text evidence="22">Has sometimes been attributed to correspond to FcR-IIC.</text>
</comment>
<comment type="sequence caution" evidence="22">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA35645" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/FCGR2BID397.html"/>
</comment>
<dbReference type="EMBL" id="U87560">
<property type="protein sequence ID" value="AAD00627.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87561">
<property type="protein sequence ID" value="AAD00628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87562">
<property type="protein sequence ID" value="AAD00629.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87563">
<property type="protein sequence ID" value="AAD00630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87564">
<property type="protein sequence ID" value="AAD00631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87565">
<property type="protein sequence ID" value="AAD00632.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87566">
<property type="protein sequence ID" value="AAD00633.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87567">
<property type="protein sequence ID" value="AAD00634.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87568">
<property type="protein sequence ID" value="AAD00635.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87569">
<property type="protein sequence ID" value="AAD00636.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87570">
<property type="protein sequence ID" value="AAD00637.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87571">
<property type="protein sequence ID" value="AAD00638.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87572">
<property type="protein sequence ID" value="AAD00639.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87573">
<property type="protein sequence ID" value="AAD00640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87574">
<property type="protein sequence ID" value="AAD00641.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87575">
<property type="protein sequence ID" value="AAD00642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87576">
<property type="protein sequence ID" value="AAD00643.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U87577">
<property type="protein sequence ID" value="AAD00644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X17653">
<property type="protein sequence ID" value="CAA35644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X17653">
<property type="protein sequence ID" value="CAA35645.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31933">
<property type="protein sequence ID" value="AAA35841.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31934">
<property type="protein sequence ID" value="AAA35842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31935">
<property type="protein sequence ID" value="AAA35843.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52473">
<property type="protein sequence ID" value="CAA36713.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR407635">
<property type="protein sequence ID" value="CAG28563.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL359541">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC031992">
<property type="protein sequence ID" value="AAH31992.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC146678">
<property type="protein sequence ID" value="AAI46679.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB050934">
<property type="protein sequence ID" value="BAB92093.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30924.1">
<molecule id="P31994-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30925.1">
<molecule id="P31994-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53414.1">
<molecule id="P31994-3"/>
</dbReference>
<dbReference type="PIR" id="JL0119">
<property type="entry name" value="JL0119"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001002273.1">
<molecule id="P31994-5"/>
<property type="nucleotide sequence ID" value="NM_001002273.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001002274.1">
<molecule id="P31994-2"/>
<property type="nucleotide sequence ID" value="NM_001002274.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001002275.1">
<molecule id="P31994-4"/>
<property type="nucleotide sequence ID" value="NM_001002275.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001177757.1">
<molecule id="P31994-3"/>
<property type="nucleotide sequence ID" value="NM_001190828.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003992.3">
<molecule id="P31994-1"/>
<property type="nucleotide sequence ID" value="NM_004001.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016856160.1">
<property type="nucleotide sequence ID" value="XM_017000671.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016856161.1">
<property type="nucleotide sequence ID" value="XM_017000672.1"/>
</dbReference>
<dbReference type="PDB" id="2FCB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.74"/>
<property type="chains" value="A=46-217"/>
</dbReference>
<dbReference type="PDB" id="3WJJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C=45-217"/>
</dbReference>
<dbReference type="PDB" id="5OCC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=43-218"/>
</dbReference>
<dbReference type="PDBsum" id="2FCB"/>
<dbReference type="PDBsum" id="3WJJ"/>
<dbReference type="PDBsum" id="5OCC"/>
<dbReference type="SMR" id="P31994"/>
<dbReference type="BioGRID" id="108507">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="DIP" id="DIP-36638N"/>
<dbReference type="ELM" id="P31994"/>
<dbReference type="IntAct" id="P31994">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="MINT" id="P31994"/>
<dbReference type="STRING" id="9606.ENSP00000351497"/>
<dbReference type="DrugBank" id="DB00054">
<property type="generic name" value="Abciximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00092">
<property type="generic name" value="Alefacept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00087">
<property type="generic name" value="Alemtuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00098">
<property type="generic name" value="Antithymocyte immunoglobulin (rabbit)"/>
</dbReference>
<dbReference type="DrugBank" id="DB00074">
<property type="generic name" value="Basiliximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00111">
<property type="generic name" value="Daclizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00095">
<property type="generic name" value="Efalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00005">
<property type="generic name" value="Etanercept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00056">
<property type="generic name" value="Gemtuzumab ozogamicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00028">
<property type="generic name" value="Human immunoglobulin G"/>
</dbReference>
<dbReference type="DrugBank" id="DB00078">
<property type="generic name" value="Ibritumomab tiuxetan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00075">
<property type="generic name" value="Muromonab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00108">
<property type="generic name" value="Natalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00110">
<property type="generic name" value="Palivizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB11767">
<property type="generic name" value="Sarilumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00081">
<property type="generic name" value="Tositumomab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="MEROPS" id="I43.001"/>
<dbReference type="GlyGen" id="P31994">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P31994"/>
<dbReference type="PhosphoSitePlus" id="P31994"/>
<dbReference type="BioMuta" id="FCGR2B"/>
<dbReference type="DMDM" id="8039788"/>
<dbReference type="CPTAC" id="CPTAC-1183"/>
<dbReference type="jPOST" id="P31994"/>
<dbReference type="MassIVE" id="P31994"/>
<dbReference type="MaxQB" id="P31994"/>
<dbReference type="PaxDb" id="P31994"/>
<dbReference type="PeptideAtlas" id="P31994"/>
<dbReference type="PRIDE" id="P31994"/>
<dbReference type="ProteomicsDB" id="54822">
<molecule id="P31994-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54823">
<molecule id="P31994-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54824">
<molecule id="P31994-3"/>
</dbReference>
<dbReference type="ABCD" id="P31994">
<property type="antibodies" value="6 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3585">
<property type="antibodies" value="816 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000236937">
<molecule id="P31994-2"/>
<property type="protein sequence ID" value="ENSP00000236937"/>
<property type="gene ID" value="ENSG00000072694"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000358671">
<molecule id="P31994-1"/>
<property type="protein sequence ID" value="ENSP00000351497"/>
<property type="gene ID" value="ENSG00000072694"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000367961">
<molecule id="P31994-3"/>
<property type="protein sequence ID" value="ENSP00000356938"/>
<property type="gene ID" value="ENSG00000072694"/>
</dbReference>
<dbReference type="GeneID" id="2213"/>
<dbReference type="KEGG" id="hsa:2213"/>
<dbReference type="UCSC" id="uc001gaz.3">
<molecule id="P31994-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2213"/>
<dbReference type="DisGeNET" id="2213"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000072694.19"/>
<dbReference type="GeneCards" id="FCGR2B"/>
<dbReference type="HGNC" id="HGNC:3618">
<property type="gene designation" value="FCGR2B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000072694">
<property type="expression patterns" value="Group enriched (blood, placenta)"/>
</dbReference>
<dbReference type="MalaCards" id="FCGR2B"/>
<dbReference type="MIM" id="152700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604590">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="611162">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P31994"/>
<dbReference type="OpenTargets" id="ENSG00000072694"/>
<dbReference type="Orphanet" id="536">
<property type="disease" value="Systemic lupus erythematosus"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28064"/>
<dbReference type="eggNOG" id="ENOG502SVEW">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214398"/>
<dbReference type="HOGENOM" id="CLU_023383_1_2_1"/>
<dbReference type="InParanoid" id="P31994"/>
<dbReference type="KO" id="K12560"/>
<dbReference type="OMA" id="DLEPPWI"/>
<dbReference type="OrthoDB" id="1246375at2759"/>
<dbReference type="PhylomeDB" id="P31994"/>
<dbReference type="TreeFam" id="TF335097"/>
<dbReference type="PathwayCommons" id="P31994"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="SignaLink" id="P31994"/>
<dbReference type="SIGNOR" id="P31994"/>
<dbReference type="BioGRID-ORCS" id="2213">
<property type="hits" value="4 hits in 868 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FCGR2B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P31994"/>
<dbReference type="GeneWiki" id="FCGR2B"/>
<dbReference type="GenomeRNAi" id="2213"/>
<dbReference type="Pharos" id="P31994">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P31994"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P31994">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000072694">
<property type="expression patterns" value="Expressed in placenta and 189 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P31994">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019864">
<property type="term" value="F:IgG binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019772">
<property type="term" value="F:low-affinity IgG receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019886">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904646">
<property type="term" value="P:cellular response to amyloid-beta"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071219">
<property type="term" value="P:cellular response to molecule of bacterial origin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021549">
<property type="term" value="P:cerebellum development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002316">
<property type="term" value="P:follicular B cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002266">
<property type="term" value="P:follicular dendritic cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002436">
<property type="term" value="P:immune complex clearance by monocytes and macrophages"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002313">
<property type="term" value="P:mature B cell differentiation involved in immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002865">
<property type="term" value="P:negative regulation of acute inflammatory response to antigenic stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001814">
<property type="term" value="P:negative regulation of antibody-dependent cellular cytotoxicity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050869">
<property type="term" value="P:negative regulation of B cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050859">
<property type="term" value="P:negative regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050710">
<property type="term" value="P:negative regulation of cytokine secretion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043318">
<property type="term" value="P:negative regulation of cytotoxic T cell degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002605">
<property type="term" value="P:negative regulation of dendritic cell antigen processing and presentation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001199">
<property type="term" value="P:negative regulation of dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002924">
<property type="term" value="P:negative regulation of humoral immune response mediated by circulating immunoglobulin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050777">
<property type="term" value="P:negative regulation of immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002638">
<property type="term" value="P:negative regulation of immunoglobulin production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032693">
<property type="term" value="P:negative regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043031">
<property type="term" value="P:negative regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902564">
<property type="term" value="P:negative regulation of neutrophil activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050765">
<property type="term" value="P:negative regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001811">
<property type="term" value="P:negative regulation of type I hypersensitivity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006911">
<property type="term" value="P:phagocytosis, engulfment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002922">
<property type="term" value="P:positive regulation of humoral immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050766">
<property type="term" value="P:positive regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905898">
<property type="term" value="P:positive regulation of response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002819">
<property type="term" value="P:regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002622">
<property type="term" value="P:regulation of B cell antigen processing and presentation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902950">
<property type="term" value="P:regulation of dendritic spine maintenance"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090264">
<property type="term" value="P:regulation of immune complex clearance by monocytes and macrophages"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045088">
<property type="term" value="P:regulation of innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010469">
<property type="term" value="P:regulation of signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009617">
<property type="term" value="P:response to bacterium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0390">IgG-binding protein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0772">Systemic lupus erythematosus</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="42"/>
</location>
</feature>
<feature type="chain" description="Low affinity immunoglobulin gamma Fc region receptor II-b" id="PRO_0000015147">
<location>
<begin position="43"/>
<end position="310"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="43"/>
<end position="217"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="218"/>
<end position="240"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="241"/>
<end position="310"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="48"/>
<end position="127"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="131"/>
<end position="213"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif">
<location>
<begin position="290"/>
<end position="295"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC-type Tyr-kinases" evidence="13">
<location>
<position position="292"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="106"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="180"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5">
<location>
<begin position="71"/>
<end position="113"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5">
<location>
<begin position="152"/>
<end position="196"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IIB3." id="VSP_002642" evidence="18">
<location>
<begin position="39"/>
<end position="45"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4 and isoform 5." id="VSP_058635" evidence="20">
<location>
<position position="46"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IIB2 and isoform 5." id="VSP_002643" evidence="16 17 18 19 20 21">
<location>
<begin position="254"/>
<end position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5017567." id="VAR_059430">
<original>Q</original>
<variation>P</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1050499." id="VAR_027045" evidence="10">
<original>Y</original>
<variation>F</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with susceptibility to SLE; associated with resistance to malaria; found at an increased frequency in African and Asian populations from areas where malaria is endemic; enhances phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro; dbSNP:rs1050501." id="VAR_015515" evidence="6 8 9 15">
<original>I</original>
<variation>T</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs148534844." id="VAR_008798" evidence="12">
<original>Y</original>
<variation>D</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA35644/CAA35645." ref="2" evidence="22">
<original>D</original>
<variation>I</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA35644/CAA35645." ref="2" evidence="22">
<original>T</original>
<variation>I</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA35644/CAA35645." ref="2" evidence="22">
<original>V</original>
<variation>G</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA35644/CAA35645." ref="2" evidence="22">
<original>P</original>
<variation>S</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="59"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="96"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="170"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="180"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="192"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="210"/>
<end position="214"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FCB"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OCC"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10064577"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12115230"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15914856"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17435165"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20385827"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2529342"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8327512"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8466861"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8756631"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9232445"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source ref="1"/>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2142460"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2529342"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2531080"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source ref="1"/>
</evidence>
<evidence key="21" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="310" mass="34044" checksum="2186F8538FF01F36" modified="2000-05-30" version="2" precursor="true">MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPNFSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISALPGYPECREMGETLPEKPANPTNPDEADKVGAENTITYSLLMHPDALEEPDDQNRI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

